N-(1-(tert-butylamino)-3-((4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-((2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-16-ethyl-4-hydroxy-15-(((2S,3S,4S,5S,6S)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)-5,9,13-trimethyl-2,10-dioxooxacyclohexadeca-11,13-dien-7-yl)-1-oxopropan-2-yl)-N-propylbenzamide

ID: ALA4440196

Chembl Id: CHEMBL4440196

PubChem CID: 155514363

Max Phase: Preclinical

Molecular Formula: C54H87N3O15

Molecular Weight: 1018.30

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN(C(=O)c1ccccc1)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)C(=O)NC(C)(C)C

Standard InChI:  InChI=1S/C54H87N3O15/c1-15-24-57(51(65)35-20-18-17-19-21-35)38(50(64)55-54(8,9)10)27-36-26-31(4)39(58)23-22-30(3)25-37(29-68-53-49(67-14)48(66-13)45(62)34(7)70-53)41(16-2)71-42(60)28-40(59)32(5)47(36)72-52-46(63)43(56(11)12)44(61)33(6)69-52/h17-23,25,31-34,36-38,40-41,43-49,52-53,59,61-63H,15-16,24,26-29H2,1-14H3,(H,55,64)/b23-22+,30-25+/t31-,32+,33-,34+,36-,37-,38?,40-,41-,43+,44-,45+,46-,47-,48+,49+,52+,53+/m1/s1

Standard InChI Key:  WGSHIQSHPYHLTM-MAFUACHCSA-N

Alternative Forms

  1. Parent:

    ALA4440196

    ---

Associated Targets(non-human)

Aliivibrio fischeri (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1018.30Molecular Weight (Monoisotopic): 1017.6137AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Budragchaa T, Westermann B, Wessjohann LA..  (2019)  Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria.,  27  (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046]

Source